Search Results - "Manmohan, V."

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    Rift Valley fever MP-12 vaccine Phase 2 clinical trial: Safety, immunogenicity, and genetic characterization of virus isolates by Pittman, Phillip R, Norris, Sarah L, Brown, Elizabeth S, Ranadive, Manmohan V, Schibly, Barbara A, Bettinger, George E, Lokugamage, Nandadeva, Korman, Lawrence, Morrill, John C, Peters, Clarence J

    Published in Vaccine (20-01-2016)
    “…Abstract An outbreak or deliberate release of Rift Valley fever (RVF) virus could have serious public health and socioeconomic consequences. A safe RVF vaccine…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Managing potential laboratory exposure to ebola virus by using a patient biocontainment care unit by Kortepeter, Mark G, Martin, James W, Rusnak, Janice M, Cieslak, Theodore J, Warfield, Kelly L, Anderson, Edwin L, Ranadive, Manmohan V

    Published in Emerging infectious diseases (01-06-2008)
    “…In 2004, a scientist from the US Army Medical Research Institute of Infectious Diseases (USAMRIID) was potentially exposed to a mouse-adapted variant of the…”
    Get full text
    Journal Article
  4. 4

    Protective antigen and toxin neutralization antibody patterns in anthrax vaccinees undergoing serial plasmapheresis by Pittman, Phillip R, Leitman, Susan F, Oro, Julio G Barrera, Norris, Sarah L, Marano, Nina M, Ranadive, Manmohan V, Sink, Bonnie S, McKee, Jr, Kelly T

    “…Recipients of licensed anthrax vaccine (AVA; Biothrax) could serve as a source of hyperimmune plasma and immunoglobulin for therapy and prophylaxis. We…”
    Get full text
    Journal Article
  5. 5

    Managing Potential Laboratory Exposure to Ebola Virus by Using a Patient Biocontainment Care Unit super(1) by Kortepeter, Mark G, Martin, James W, Rusnak, Janice M, Cieslak, Theodore J, Warfield, Kelly L, Anderson, Edwin L, Ranadive, Manmohan V

    Published in Emerging infectious diseases (01-06-2008)
    “…One-sentence summary for table of contents: Recommendations are needed for management of potential laboratory exposure to a Biosafety Level 4 pathogen. In…”
    Get full text
    Journal Article
  6. 6

    Managing Potential Laboratory Exposure to Ebola Virus by Using a Patient Biocontainment Care Unit1 by Kortepeter, Mark G., Martin, James W., Rusnak, Janice M., Cieslak, Theodore J., Warfield, Kelly L., Anderson, Edwin L., Ranadive, Manmohan V.

    Published in Emerging infectious diseases (01-06-2008)
    “…One-sentence summary for table of contents: Recommendations are needed for management of potential laboratory exposure to a Biosafety Level 4 pathogen. In…”
    Get full text
    Journal Article
  7. 7

    Link between energy and computation in a physical model of Hopfield network by Kumar, A., Manmohan, V., Uday Shankar, M., Vishwanathan, M., Chakravarthy, V.S.

    “…Linking information processing and energy flows via thermodynamics, Landauer (1961) proposed that irreversible computational processes have an inevitable…”
    Get full text
    Conference Proceeding
  8. 8

    Department of the Army Regulations and Policies for Hearing Conservation by Goldstein, Jeffrey, Ranadive, Manmohan V., Rosenberg, Donald M.

    “…Authority for the implementation of hearing conservation programs within the Department of the Army is established in Army Regulation 40-5, “Preventive…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Biological effects of trinitrotoluene from exposure below the threshold limit value by Morton, A R, Ranadive, M V, Hathaway, J A

    “…Statistically significant rises in serum glutamic oxalacetic transaminase and lactic dehydrogenase determinations occurred at exposures to TNT of 0.8 mg/m3 and…”
    Get more information
    Journal Article